Sign In
Buy KVUE
$17.32
-0.0300 (-0.173%)
At Close: Jun 02, 2026
Shareholder Alert: The Ademi Firm investigates whether Kenvue Inc. is obtaining a Fair Price for its Public Shareholders
11:14am, Monday, 03'rd Nov 2025
MILWAUKEE , Nov. 3, 2025 /PRNewswire/ -- The Ademi Firm is investigating Kenvue (NYSE: KVUE) for possible breaches of fiduciary duty and other violations of law in its transaction with Kimberly-Clark.
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion
10:44am, Monday, 03'rd Nov 2025
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Why Tylenol Maker Kenvue Stock Just Popped
10:43am, Monday, 03'rd Nov 2025
Kimberly-Clark will buy Kenvue for $48.7 billion. Kenvue is the maker of Tylenol.
Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.
10:33am, Monday, 03'rd Nov 2025
D.E. Shaw, one of the Tylenol-maker's largest shareholders, stood to lose over $200 million but is now expected to break even on its bet.
Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant
09:57am, Monday, 03'rd Nov 2025
Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion. CNBC's David Faber breaks down the details.
Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal
09:30am, Monday, 03'rd Nov 2025
While all the Mag 7 but Nvidia (NVDA) reported their quarterly earnings, 135 SPX companies and 25 NDX companies are on the docket this week. Kevin Hincks points to Palantir's (PLTR) report after Monda
Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger
09:16am, Monday, 03'rd Nov 2025
Kleenex maker's deal for troubled Johnson & Johnson spinoff comes amid lawsuits and regulatory scrutiny
Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal
09:15am, Monday, 03'rd Nov 2025
This is a developing story.
Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal
08:40am, Monday, 03'rd Nov 2025
CNBC's David Faber joins 'Squawk Box' with the latest news.
Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion
08:27am, Monday, 03'rd Nov 2025
Kenvue's stock, which had hit a record low in recent weeks, was headed for its best day ever while Kimberly-Clark's stock tumbled.
Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal
08:24am, Monday, 03'rd Nov 2025
Kenvue missed Wall Street estimates for third-quarter sales on Monday, while it also announced its acquisition by Kimberly-Clark for about $48.7 billion.
KVUE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Kenvue Inc. is Fair to Shareholders
08:02am, Monday, 03'rd Nov 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Kenvue Inc. (NYSE: KVUE) to Kimberly-Clark Corporation for $3.50 per share in cash plus 0
Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant
07:49am, Monday, 03'rd Nov 2025
Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion. The combined company would bring together brands like Huggies and Kleenex with the likes of Ba
Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion
06:50am, Monday, 03'rd Nov 2025
Kimberly-Clark will buy Kenvue for cash and stock.
Kimberly-Clark to Buy Tylenol Maker Kenvue
06:44am, Monday, 03'rd Nov 2025
The $48.7 billion deal, which includes debt, combines the maker of Huggies diapers with the owner of the painkiller maker.
